Avsnitt
-
There have been countless advances in controller therapies for asthma, but our go-to rescue inhaler, a quick-relief bronchodilator, hasn’t changed in decades.
In this episode of The Itch Review, we spotlight “As-Needed Albuterol–Budesonide in Mild Asthma” published in The New England Journal of Medicine, May 19, 2025. This article looks at the BATURA trial, which tested whether adding budesonide to albuterol rescue inhalers cuts exacerbations in adults whose mild asthma remains uncontrolled on occasional albuterol/short-acting beta agonist (SABA) therapy.
Could this combo inhaler really cut severe asthma attacks in people with mild disease?
What we cover in our episode about the BATURA trial:Understanding asthma: In asthma, your airways both tighten up and get swollen. Treating both the tightness and the swelling right when you feel symptoms could stop a full-blown attack.All-online trial: BATURA used telehealth to enroll 2,516 people with mild asthma from across the U.S. and ran the study until it saw a preset number of 172 serious attacks.Big takeaways: The combo inhaler cut serious attacks by almost half, halved yearly flare-ups, and slashed steroid use by 63%. All without people needing to use their medication more often.Why it ended early: An independent safety board reviewed the data mid-trial and concluded that the combo inhaler was so clearly better that it would’ve been unfair to continue giving anyone the old treatment.What’s next: We still need studies on teens and children to ensure that these same benefits hold true for younger patients.GET THE INFOGRAPHIC PDF HERE
***
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores the latest allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.
***
This podcast is made in partnership with The Allergy & Asthma Network.
Thanks to AstraZeneca for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Have you ever wondered whether fexofenadine (Allegra®) really doesn’t make you drowsy?
In this episode of The Itch Review, we dissect a July 2024 systematic review from Current Medical Research & Opinion, “Why fexofenadine is considered a truly non-sedating antihistamine with no brain penetration.”
This rigorous systematic review pools over 60 human studies from PET brain-scan trials and Proportional Impairment Ratio (PIR) tests to driving-simulator research and real-world quality-of-life surveys. It looks to answer one question: Does fexofendine ever sneak past the blood–brain barrier and slow you down like first-generation allergy meds?
This episode looks at the evolution of H1 antihistamines from first-generation drugs like diphenhydramine to today’s second-generation options (cetirizine, loratadine, and fexofenadine) to show how each interacts with the blood–brain barrier (BBB) and why that matters for sedation.
We highlight the review’s key studies:
PET Imaging: Measuring H1-receptor occupancy. Fexofenadine registers <1%, even at high dosesPIR Analyses: Proportional Impairment Ratio tests show virtually zero cognitive or motor impairment when taking fexofenadineDriving & Aviator Trials: Side-by-side comparisons with diphenhydramine, alcohol, and fexofenadineFinally, we dive into real-world outcomes on reaction times, work-and-school performance, pediatric safety, and even NASA’s approval for pilot use.
GET THE INFOGRAPHIC TO FOLLOW ALONG
***
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores the latest allergy and immunology studies through 30-minute conversations that are accessible for everyone. This podcast aims to support busy clinicians, patients, and caregivers in staying updated on current research. Each episode provides valuable insights from key journal articles and includes a convenient one-page infographic in the show notes for easy reference.
***
This podcast is made in partnership with The Allergy & Asthma Network.
Thanks to Opella for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Saknas det avsnitt?
-
Stepping into young adulthood also means stepping up as the primary manager of your food allergies.
For teens and young adults with food allergies, early adulthood is an exciting but challenging shift. It’s the first time you’re the primary communicator, managing everything from dining halls to doctor’s appointments on your own. Add in new living spaces, new friends, and a growing social life, and there’s a lot to navigate.
Dr. Theresa Bingemann joins Kortney and Dr. Payel Gupta to unpack how food allergy management changes as you step into early adulthood. We cover self-advocacy skills, emergency preparedness, how to create allergy-friendly spaces in shared housing, and tips for navigating social life safely. Plus, we dive into practical advice for managing stress, staying emotionally healthy, and finding your footing in this new phase of life.
What we cover in our episode about managing food allergies in young adults:Self-advocacy matters. Learn how to speak up about your allergies with confidence.Planning ahead for emergencies. Practicing with an epinephrine device is not just for kids! Plus, knowing the available campus resources is key to feeling secure in your food allergy management.Creating a safe living space. Tips for setting up allergy-friendly dorm rooms and kitchens with roommates.Navigating social life. How to handle parties, dating, and dining out while staying safe.Managing emotional well-being. Support strategies for handling anxiety, stress, and the transition to independence.Episode 6 in our “Food Allergies: Ages & Stages” series
Across six episodes, we explore how food allergies show up and shift through different phases of life, from introducing solids in infancy to navigating school and adapting in adulthood. We’re here with evidence-based info, expert insights, and lived experience to guide you through it all.
Episode 110: Early Allergen IntroductionEpisode 111: Food Allergy Basics for Newly Diagnosed FamiliesEpisode 112: Managing Food Allergies in Babies and ToddlersEpisode 113: Managing Food Allergies in School-Age ChildrenEpisode 114: Managing Food Allergies in TeensAAAAI Ages & Stages PDFs
Food Allergy Stages: Young Adults (18–21 years)Thanks to Genentech and Aquestive for sponsoring this episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Independence, risk-taking, and peer pressure. Welcome to the teenage years with food allergies!
Managing food allergies during the teen years poses new challenges. Tweens and teens are gaining independence, navigating social pressures, and taking more responsibility for their health. But this is also the stage where risky behavior peaks, and the risk for severe allergic reactions is highest. That’s why clear communication and trust matter more than ever.
In this episode of our Food Allergy Stages Series, Dr. Travis Miller joins Kortney and Dr. Payel Gupta to unpack how food allergy management changes from ages 12 to 18. We talk about empowering teens through shared decision-making, building trust between parents and teens, and developing essential life skills like label reading, restaurant communication, and self-advocacy. We also dive into difficult topics like bullying, alcohol, and mental health. Finally, we address why emotional support is just as important as carrying an epinephrine auto-injector.
What we cover in our episode about managing food allergies in teens:Why trust matters. Teens are more likely to follow allergy routines when they feel heard and involved.Empowering independence. From grocery shopping to reading labels, this is the age to start turning over the reins.Talking about risky behavior. Alcohol and dating can put teens with food allergies at higher risk.Bullying and boundaries. Learn how to spot signs of bullying and who can help your teen feel safe and supported.Mental health and identity. Food allergies can affect confidence. We share ways to support emotional wellness and self-esteem.Episode 5 in our “Food Allergies: Ages & Stages” series
Across six episodes, we explore how food allergies show up and shift through different phases of life, from introducing solids in infancy to navigating school and adapting in adulthood. We’re here with evidence-based info, expert insights, and lived experience to guide you through it all.
Episode 110: Early Allergen IntroductionEpisode 111: Food Allergy Basics for Newly Diagnosed FamiliesEpisode 112: Managing Food Allergies in Babies and ToddlersEpisode 113: Managing Food Allergies in School-Age ChildrenThanks to Genentech and Aquestive for sponsoring this episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
How do you help your child go from knowing they have a food allergy to actually managing it in everyday life?
This is the stage when everything starts to shift. Between the ages of 5 and 11, your child is learning how to describe symptoms, speak up at school, and navigate birthday parties. They’re also watching you closely and picking up how to talk about food allergies based on how you do it.
In this episode of our Food Allergy Stages & Stages Series, pediatric allergist and immunologist Dr. Dave Stukus joins Kortney and Dr. Payel Gupta to talk about how food allergy care changes in the early school years.
What we cover in our episode about managing food allergies in ages 5 to 11:Build awareness early. Teach kids to name their allergens, recognize symptoms, and use simple words to describe how they feel.Model safe behavior. Kids learn by watching you read labels, ask questions, and stay calm.Normalize epinephrine. Practice with a trainer and talk about it openly so it feels familiar, not scary.Prepare for real-life situations. From school to parties, give kids scripts and strategies to feel confident and included.Support emotional wellness. Watch for signs of anxiety and help your child feel empowered, not afraid.Episode 4 in our “Food Allergies: Ages & Stages” series
Across six episodes, we explore how food allergies show up and shift through different phases of life, from introducing solids in infancy to navigating school and adapting in adulthood. We’re here with evidence-based info, expert insights, and lived experience to guide you through it all.
Episode 1: Early Allergen Introduction (Ep. 110)Episode 2: Food Allergy Basics for Newly Diagnosed Families (Ep. 111)Episode 3: Managing Food Allergies in Babies and Toddlers (Ep. 112)Made in partnership with the Allergy & Asthma Network. Thanks to Genentech and Aquestive for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
Timestamps
01:42 Breaking down food allergy care by age group
02:58 What kids need to know about living with food allergies
04:47 Sharing allergy information without creating fear
06:40 Talking to children about symptoms
08:40 What to tell kids about epinephrine
11:04 Helping kids without passing on fear or anxiety
13:18 Mental health signs related to food allergies
16:04 Managing allergens in the home environment
19:50 The pros and cons of allergy tables at school
21:42 Communicating with schools and daycares
25:29 Preparing for parties and sleepovers
27:33 Final tips for parenting kids with food allergies (ages 5–11)
-
How do you keep a baby or toddler safe with food allergies when they put everything in their mouths and can’t yet explain how they feel?
This stage of life is full of firsts, not just for your child, but for you as a parent managing food allergies. From introducing new foods to navigating daycare and watching for reactions in a child who can’t speak yet, there are countless moments you’ll need to manage. This episode focuses on building safe habits early, empowering caregivers, and showing how simple routines (like label reading or toy wiping) can make a big difference.
Allergist Dr. Basil Kahwash joins Kortney and Dr. Payel Gupta to explore how food allergy care evolves from infancy through preschool. They cover real-life, practical strategies from wiping toys and watching for symptoms to managing daycare risks and building early self-advocacy skills.
What we cover in our episode about managing food allergies in toddlers:Why age matters. Babies, toddlers, and preschoolers each need different safety strategies.What symptoms look like. Learn how reactions can show up in babies who can’t talk.Introducing new foods. Why early introduction still matters even after a new food allergy diagnosis.Daycare safety tips. How to prep caregivers and keep your child protected.Building habits early. From label reading to toy wiping, young kids learn by watching you.Episode 3 in our “Food Allergies: Ages & Stages” series
Across six episodes, we explore how food allergies show up and shift through different phases of life, from introducing solids in infancy to navigating school and adapting in adulthood. We’re here with evidence-based info, expert insights, and lived experience to guide you through it all.
Episode 1: Early Allergen Introduction (Ep. 110)Episode 2: Food Allergy Basics for Newly Diagnosed Families (Ep. 111)Episodes to build a better food allergy foundation:
Episode 59: What is Anaphylaxis and When to Use EpinephrineEpisode 95: The Science Behind Allergic ReactionsEpisode. 97: The Nuances of Food Allergy Testing Episode 98: Food Allergy Treatment and ManagementMade in partnership with The Allergy & Asthma Network.
Thanks to Genentech and Aquestive for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Just diagnosed with a food allergy and feeling lost? You’re not alone and don’t have to figure out food allergy life by yourself. We’re here to help you understand food allergy basics: what causes allergic reactions, how to recognize symptoms, and how to manage your allergy safely, every day.
This is the second episode in our Food Allergies: Ages & Stages, and it’s all about building a strong foundation after a new diagnosis. Whether it’s your child, your partner, or you who was recently diagnosed, Kortney and Dr. Payel Gupta walk through everything you need to know in those early days. From understanding how allergic reactions work to learning about life-saving tools like epinephrine, and new management options like OIT and omalizumab.
Dr. G explains what causes your immune system to misfire, how fast symptoms can appear, and why no two reactions are the same. We also dive into real-life strategies like carrying your epinephrine device, knowing when and how to use it, and navigating social situations. Plus, Kortney shares personal tips that have helped her live safely with food allergies for over 30 years.
What we cover in our episode about managing a new food allergy diagnosisWhat just happened?! We explain what causes allergic reactions, including the roles of IgE, histamine, and mast cells.Are all allergic reactions the same? Learn how quickly reactions can occur and why symptoms aren’t always predictable.Why is epinephrine so important? When to use epinephrine, how to use it, and why antihistamines aren't enough.New options to help manage food allergies. A look at treatments like OIT and omalizumab (Xolair) and why you still need to carry your epi.Peace of mind with an action plan. What to include in a Food Allergy Action Plan and how to help others take your allergy seriously.Episode 2 in our “Food Allergies: Ages & Stages” series
Across six episodes, we explore how food allergies show up and shift through different phases of life, from introducing solids in infancy to navigating school and adapting in adulthood. We’re here with evidence-based info, expert insights, and lived experience to guide you through it all.
Episodes mentioned to help build your foundation:
Episode 59: What is Anaphylaxis and When to Use EpinephrineEpisode 95: The Science Behind Allergic ReactionsEpisode 98: Food Allergy Treatment and ManagementEp. 110: Early Introduction of Allergenic Foods – Preventing Food Allergies Before They StartMade in partnership with The Allergy & Asthma Network.
Thanks to Genentech and Aquestive for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Did you know you could potentially reduce your baby’s risk of developing food allergies by up to 80%?
That’s the power of early allergen introduction. Feeding a baby the top 9 allergens consistently starting between 4 to 6 months can make a life-changing difference.
We’re launching a brand-new series about food allergies at various stages of life. Whether you’re just starting solids, navigating a new diagnosis, or in a new stage of life, this series is here to support you with evidence-based tips and real talk. In this first episode, Kortney and Dr. Payel Gupta explore how to potentially prevent food allergies before they even develop.
Why do you want to know more about introducing allergens to baby?For years, parents were told to wait until toddlers were older before introducing allergenic foods. But groundbreaking research, including the LEAP, LEAP-On, and PETIT studies, turned that advice on its head.
We no longer wait to feed babies food allergens. Instead, early (around 4–6 months) and sustained exposure to top allergens like peanut and egg is recommended for all babies. In this episode, Dr. G and Kortney explain the studies, walk you through how to do it safely, and bust common myths that leave parents confused or anxious.
What we cover in our episode about early allergen introductionWhy guidelines changed: Learn how the LEAP & PETIT studies reshaped allergy prevention.How to introduce the top 9 allergenic foods safely, including forms that are appropriate for infants.What “sustained exposure” means and how often to serve allergens after that first taste.How eczema increases allergy risk and what transcutaneous sensitization means.What allergic signs to watch for: mild hives vs. serious allergic reactions and when to call the doctor.More resources about food allergy preventionUSDA Updates Dietary Guidelines to Include Introduction of Food AllergensDelaware Adopts Law Covering Early Introduction of Food AllergensWhat is a food allergy?American Academy of Pediatrics Early Feeding GuidelinesAAAAI / ACAAI handouts on introducing peanut & eggFARE: How to Use Peanut Puffs SafelySolid Starts: Peanut Butter Guide (Creative Ways to Serve)PreventAllergies.org Recipe LibraryOur infant anaphylaxis episode (with Dr. Mike)Made in partnership with the Allergy & Asthma Network. Thanks to Genentech and Aquestive for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Have you wondered why having more drug options matters for chronic rhinosinusitis with nasal polyps?
In the inaugural episode of our new series, The Itch Review, co-hosts Kortney and Dr. Payel Gupta, along with special guest Dr. Michael Blaiss, unpack the journal article "Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps," published in the New England Journal of Medicine on March 1, 2025.
This article is about the Phase III WAYPOINT trial of tezepelumab. Already approved for severe asthma, this once-monthly biologic is now showing promise in chronic rhinosinusitis with nasal polyps (CRSwNP). Over 52 weeks, 408 patients were randomized to receive 210 mg of tezepelumab every four weeks or placebo. Researchers tracked nasal-polyp scores, congestion, sense of smell, and rates of rescue surgery.
In this episode, we provide a brief overview of what CRSwNP is, why inflammation drives polyp formation and how blocking TSLP fits into today’s biologics options. We’ll walk you through the WAYPOINT Phase III design, explain the primary and secondary endpoints, and translate the headline results into what they mean for real-world patients who’ve exhausted their treatment options.
➡️ Get the infographic here.
What we cover in our episode about treating chronic rhinosinusitis with nasal polyps with tezepelumabCRSwNP basics & tezepelumab mechanism of action: How nasal polyps form and why targeting TSLP can reduce inflammationWAYPOINT design: 52-week, placebo-controlled Phase III study in 408 patients Primary endpoints: Mean change in nasal polyp score and nasal-congestion scoreSecondary endpoints: Smell recovery, need for rescue surgery or systemic steroids, and quality-of-life measuresWhy choice matters: Every CRSwNP patient responds differently, and having more treatment options means more chances to find the right fitMade in partnership with The Allergy & Asthma Network. Thanks to AstraZeneca for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Ever wonder who’s working behind the scenes to improve allergy care nationwide?
In this episode, we sit down with Dr. James Tracy, the 2024-2025 president of the American College of Allergy, Asthma & Immunology (ACAAI), to explore how the College supports both patients and clinicians. Dr. Tracy shares how he got involved, what drives his leadership, and what’s ahead for the future of allergy and asthma care.
From workforce shortages to the promise of AI in medicine, this conversation takes you behind the curtain of the specialty. Plus, we dig into how patients and providers alike can make a difference through advocacy.
What we cover in our episode about ACAAI, leadership & allergy care
Dr. Tracy’s unique path to leadership: How his non-traditional journey from practicing in rural Nebraska to leading the ACAAI shaped his approach to advocacy and patient care.Creating leadership opportunities: Why mentorship and involvement in ACAAI committees can open doors for clinicians, fellows-in-training, and future leaders in allergy and immunology.Patient tools that make a difference: Free ACAAI resources that help patients better understand and manage their conditions.The evolving role of the allergist: How allergists are uniquely trained to manage complex conditions and why that matters as technology, treatment options, and care delivery evolve.Future-focused leadership at ACAAI: Dr. Tracy’s vision for tackling workforce shortages, embracing AI and gene editing, and keeping patient care at the center of innovation.Resources:
Asthma Allergy Day on Capitol HillMore information about advocacyThe American College of Allergy Asthma and Immunology Patient ResourcesThe American College of Allergy Asthma and Immunology Allergist Finder -
Ever wonder how culture and language barriers affect diagnosing chronic spontaneous urticaria (CSU) in Latinx patients?
In this episode, allergist Dr. Juanita Mora joins Kortney and Dr. Gupta to discuss chronic spontaneous urticaria (hives) and the unique challenges faced by the Latinx community. They highlight the importance of cultural competency in health care and the barriers that Latinx patients often encounter, such as language differences and access to specialists. They also discuss how Latinx patients are often not given all treatment options for hives, such as biologics.
Dr. Mora emphasizes the importance of having resources available in Spanish and encourages patients and families to advocate for their care. They explore practical tips on how technology, family support, and proper patient education can help overcome barriers, leading to better diagnosis, treatment, and improved quality of life for Hispanic patients managing CSU.
What we cover in our episode about chronic hives in the Latinx community:
Diagnosing hives in skin of color: How CSU symptoms can present differently on darker skin tones, making accurate diagnosis harder. Overcoming barriers for Latinx patients: The specific hurdles the Latinx community faces like language barriers, limited access to Spanish-speaking allergists, and challenges obtaining advanced treatments such as biologics.Role of family and community support: How involving family members and community leaders can improve CSU awareness, reduce stigma, and encourage patients to seek timely medical treatment.Importance of Spanish-language patient education: Why accessible, culturally relevant education and resources in Spanish are essential for empowering Latinx patients to manage their CSU effectively.Cultural beliefs and CSU diagnosis: How cultural perceptions around health and family influence the timing of diagnosis and willingness to seek medical care.Resources Spanish
¿Qué es la urticaria crónica?Urticaria Crónica - Dr. Antonio Olvera Urticaria crónica espontánea/idiopática (erupción crónica)Protocolo urticaria cronicaResources English
Chronic Urticaria Management, Resources & Glossary of TermsChronic Hives: 10 Actions to Support Your Mental HealthWhy Are My Hives Not Going Away?Made in partnership with The Allergy & Asthma Network. Thanks to Novartis for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Have you ever wondered if steroids are the best choice for managing your eczema?
While both topical and oral steroids offer quick relief from severe eczema flares, understanding their long-term risks and safer alternatives can dramatically improve your quality of life.
In this episode, Dr. Mondana Ghias joins Kortney and Dr. Gupta to discuss the complex role of systemic corticosteroids in eczema management. They dive deep into the short-term relief that steroids provide for severe eczema symptoms and emphasize why steroids must be approached cautiously due to potential side effects and dependency risks.
Dr. Ghias also highlights the unique challenges of eczema care for individuals with skin of color, addressing differences in treatment response and the common issue of hypopigmentation caused by topical steroids.
What we cover in our episode about steroid use in eczema treatment:Role of Systemic Steroids: When steroids are necessary and how they quickly manage severe eczema flares.Risks and Side Effects: Understanding the serious long-term effects of systemic and topical steroids.Steroid Withdrawal: Recognizing the signs of steroid withdrawal and strategies to manage rebound effects.Challenges of Topical Steroids for Skin of Color: The unique risks of steroid use and managing hypopigmentation.Alternatives to Steroids and Innovative Treatments: The rise of biologics and targeted therapies offering safer, long-term solutions.The Importance of Specialist Care: Working with a dermatologist or allergist will help you find a sustainable long-term management plan.Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Ever wonder if the “asthma shot” from the ER, or those go-to steroid pills for your asthma flares, might be doing more harm than good?
Dr. Dipa Sheth joins us to discuss the common pitfalls of relying too heavily on oral corticosteroids (OCS), also known as oral steroids. We unpack why these systemic medications should generally be reserved for short-term use. She also shares how improving asthma control can help you avoid frequent steroid use in the first place.
Although oral steroids can effectively treat asthma flare-ups in emergency settings, overuse poses significant risks, from adrenal insufficiency to osteoporosis. We dig into ways patients can proactively manage their asthma, reduce ER visits, and talk to healthcare providers about preventive treatments (like inhalers or biologics for asthma) that keep inflammation in check without the side effects of frequent steroid use.
Note: Although we discuss oral corticoid steroids, they can also be given as injections or via IV drip for asthma. We would also like to refer to them as systemic steroids as they impact the entire body, unlike inhaled steroids, which target the airways and lungs.
What we cover in our episode about oral steroid overuseUnderstanding Oral Corticosteroids (OCS): Learn what these steroids (often called the “asthma shot” in the ER) are and how they can help with severe flare-ups.Why Overusing Steroids Can Be Risky: Discover the potential long-term side effects of relying on systemic steroids (pills, injections, or IV), from adrenal insufficiency and osteoporosis to more frequent infections.Short-Term Fix vs. Lasting Relief for Asthma Care: Learn how urgent care or ER visits may mask an under-managed condition and why seeing a specialist can improve asthma control.Safer Alternatives to OCS: Explore inhaled corticosteroids, biologics, and other preventive treatments that target asthma at its source, reducing the need for frequent steroids.Taking Control and Reducing ER Visits: Get practical strategies for working with your healthcare provider to minimize steroid use, prevent flare-ups, and break free from the cycle of repeated steroid courses.This podcast is made in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute for professional medical advice. If you have any medical concerns, always consult with your healthcare provider.
-
What does "control" mean when managing allergic conditions, and how can you achieve it?
When you have asthma, eczema, nasal polyps, or other conditions caused by type 2 inflammation, reaching a state of control can dramatically improve your quality of life. But what does "control" really mean? Is it the same as a cure? And what steps should you take if your current treatment isn't working?
In this episode, Dr. Payel Gupta and Kortney dive deep into the idea of control in the context of Type 2 inflammation. They explain that control doesn't mean you'll never experience symptoms again. Rather, it's about having fewer, milder flare-ups and the freedom to live your life more comfortably.
Dr. Gupta explains what control means for various conditions, why it matters, and how recognizing signs of poor control can protect against long-term complications. Kortney shares her own experience managing asthma and eczema with biologics, highlighting why symptom tracking and regular check-ins with your doctor are essential, even when you’re feeling good.
What we cover in our episode about achieving control over Type 2 inflammation:Defining Control in Type 2 Inflammation: Learn what control actually looks like. Discover the difference between controlling symptoms and curing the condition entirely.Why Achieving Control Matters: Find out why uncontrolled Type 2 inflammation can lead to worsening symptoms, frequent hospital visits, increased medication needs, and significantly impact your day-to-day life.Managing Multiple Conditions and the Role of Specialists: Understand why having more than one Type 2 inflammatory condition can lead to a "domino effect," worsening overall health. Learn how specialists like allergists can help you manage multiple conditions effectively.Treatment Options for Controlling Type 2 Inflammation: Get an overview of available treatments, including biologic therapies specifically designed to target underlying inflammation pathways. Understand the role these medications play in improving quality of life.Practical Tips for Managing Symptoms at Home: Learn ways to reduce inflammation by identifying and minimizing triggers, allergy-proofing your environment, and adopting healthier lifestyle practices.More episodes that will help you:
Ep. 101 What is Type 2 InflammationEp. 98 Food Allergy Treatment and ManagementEp. 87 What biologic therapies are available for allergic conditions?Ep. 85 Navigating Biologic Therapy – What You Need to KnowEp. 78 Chronic Spontaneous Urticaria TreatmentsEp. 56 Biologic Therapies for AsthmaMade in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Can you slow down the atopic march and prevent kids from developing more allergic diseases?
Type 2 inflammation plays a central role in allergic diseases, which impact children from infancy through adulthood. From eczema and asthma to food allergies and allergic rhinitis, these conditions are all connected through an underlying immune response: Type 2 inflammation. But is there a way to prevent the progression of these diseases?
In this episode, Dr. Payel Gupta and Kortney are joined by Dr. Priya Bansal to explore how Type 2 inflammation manifests in children, the concept of the atopic march, and whether treatments like immunotherapy or biologics can alter the course of the diseases.
Many parents aren’t aware of the atopic march until their child starts developing multiple allergic conditions. Understanding how Type 2 inflammation progresses and when to intervene can be crucial in managing these diseases early. Dr. Bansal shares her expert insights on the best time to seek treatment and how biologics may help some children break the cycle of inflammation.
What we cover in our episode about type 2 inflammation in childrenUnderstanding Type 2 Inflammation in Children: Understand type 2 inflammation’s role in conditions like eczema, asthma, allergic rhinitis, and food allergies. Learn why children with one allergic condition often develop others over time.The Atopic March: Discover why some children with eczema go on to develop asthma and food allergies. Learn why early intervention can make a difference.Immunotherapy and Biologics: Can They Change the Course of Disease? Understand how allergy shots, OIT, SLIT and biologics work, when they are recommended, and whether they can stop or slow down the atopic march in children.When to See an Allergist & Parental Concerns About Treatment: Learn the signs that indicate your child may need an allergist evaluation. Plus, we address common concerns about aggressive treatment options, including steroids and biologics.Managing Type 2 Conditions at Home & School: Practical tips for parents navigating food allergic diseases.Made in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Why do conditions like asthma, nasal polyps, or eczema become more severe when they coexist?
Kortney and Dr. Payel Gupta are joined by Dr. Michael Blaiss to explore the common thread linking multiple allergic and inflammatory diseases: Type 2 Inflammation. If you’ve ever wondered why certain conditions often appear together, this deep dive will help you connect the dots.
Type 2 Inflammation is a hot topic in immunology because it’s the engine that drives many allergic and inflammatory diseases. It’s also the key to modern treatment strategies, including targeted biologic therapies. Dr. Blaiss explains how clinicians recognize multiple Type 2-driven conditions in the same patient, why it is important to know the connection between multiple conditions and Type 2 inflammation, and the big-picture benefits of treating inflammation aggressively to prevent complications.
What We Cover in our Episode about The Diseases Related to Type 2 InflammationConditions Related to Type 2 Inflammation: Explore how chronic rhinosinusitis with nasal polyps (CRSwNP), rhinitis, asthma, atopic dermatitis (eczema), prurigo nodularis, eosinophilic esophagitis (EoE), and food allergies can all share a common inflammatory pathway.The Likelihood of Having Multiple Type 2 Conditions: How often do patients have more than one condition related to Type 2 Inflammation, and why is recognizing overlap a potential game-changer for diagnosis and treatment?Treating the Root Inflammation vs. Individual Symptoms: Discover how clinicians decide whether to address each condition separately or tackle the underlying Type 2 inflammatory process affecting them all.Markers & Personalized Medicine: Dr. Blaiss discusses whether potential tests, such as eosinophil counts or IgE levels, can confirm Type 2 inflammation. He also explains how knowing you have Type 2 Inflammation can help guide targeted therapy.Prevention & Aggressive Intervention: Understand why it’s crucial to treat inflammation early to reduce the risk of developing multiple Type 2 conditions and how this proactive approach benefits long-term health.Want to know more? Type 2 Inflammation Overview – Explains the role of Type 2 inflammation in conditions like asthma and nasal polyps.
This podcast is for informational purposes only and does not substitute for professional medical advice. If you have any medical concerns, always consult with your healthcare provider.
Produced in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.
-
What do asthma, eczema, EoE, and nasal polyps have in common? They all stem from Type 2 inflammation!
Type 2 inflammation is a major cause of many allergic and inflammatory conditions, yet it remains widely misunderstood. In this first episode of our four-part series on Type 2 Inflammation, we discuss the basics, unpack its impact on the immune system, explain how it contributes to chronic inflammation in the body, and explain why it matters for treatment and management.
What we cover in our episode about Type 2 InflammationUnderstanding Inflammation: Inflammation is your body’s natural defence mechanism, but it can become problematic when it turns chronic.Normal vs. Chronic Inflammation: Not all inflammation is bad! Learn the difference between the body’s normal immune response and long-term chronic inflammation.What Sets Type 2 Inflammation Apart? Unlike other immune responses, Type 2 inflammation involves a specific pathway.Key Players in Type 2 Inflammation: Th2 cells, cytokines (IL-4, IL-5, IL-13), IgE antibodies, and eosinophils.Measuring Type 2 Inflammation: How blood tests can help determine if Type 2 inflammation is contributing to your symptoms.Want to know more? Type 2 Inflammation Overview – Explains the role of Type 2 inflammation in conditions like asthma and nasal polyps.
This podcast is for informational purposes only and does not substitute for professional medical advice. If you have any medical concerns, always consult with your healthcare provider.
Produced in partnership with The Allergy & Asthma Network. Thanks to Sanofi and Regeneron for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.
-
We’re celebrating 100 episodes and six years of The Itch Podcast!
In this special episode, Dr. Payel Gupta and Kortney reflect on their journey—sharing insights from their experiences as a doctor-patient duo. Dr. G talks about how the podcast has influenced her as a provider, while Kortney shares how it has literally changed her life.
We also introduce The Journal Club, a brand-new series in which we unpack the latest journal articles in our famous, easy-to-digest style.
What We Cover in This Episode:Why Kortney decided to share her story about allergies, asthma, and eczema.Why Dr. Gupta became an allergist and how her personal journey shaped her career.The impact of patient advocacy—why Dr. G is passionate about empowering patients.The Itch Podcast's partnership with Allergy & Asthma Network and how it’s raising awareness and education.Lessons from six years of podcasting—what we’ve learned from our guests, experts, and YOU, our listeners.Introducing The Journal Club—a new series unpacking medical research in a simple and relatable way. -
What would you do if your baby had a severe allergic reaction?
Recognizing and treating anaphylaxis in babies can be overwhelming, but knowing the right signs and symptoms can help you decide when to use epinephrine or distinguish it from a cold. Pediatric allergist Dr. Michael Pistiner joins us to discuss how to recognize anaphylaxis in infants, when to use epinephrine, and why early food introduction matters.
Understanding food allergies in infants, anaphylaxis symptoms, and emergency treatment is essential for parents and caregivers to act quickly and confidently. This episode will give you the confidence to respond in an emergency.
What We Cover in Our Episode on Infant AnaphylaxisWhat is anaphylaxis, and how does it present differently in infants vs. older children?How to differentiate an allergic reaction from common childhood illnesses.Why early allergen introduction is crucial andHow over-testing can lead to unnecessary worry.When to use epinephrine vs. antihistamines for treating reactions.Parental fears about epinephrine and why it’s always the safest choice in an emergency.When to call 911 after administering epinephrine.Why carrying two epinephrine auto-injectors is essential for managing severe reactions.More resources about infant anaphylaxis:
More from Dr. Pistiner about infant anaphylaxisWhat is EpinephrineMore About Food AllergiesMore About AnaphylaxisFood Allergy Treatment & ManagementLiving with Food Allergies GuideWhat Can You Do If You Can’t Afford Allergen-Free Foods?What if I Can’t Afford My Allergy Medications?Early Introduction GuidelinesThis podcast is made in partnership with The Allergy & Asthma Network. Thanks to Kaléo for sponsoring today’s episode.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
-
Is there a cure for food allergies? Unfortunately, not yet. However, exciting new treatments are emerging that offer hope and improved quality of life for those managing food allergies.
Dr. Maya N. Gharfeh joins us to explore innovative options for treating food allergies. In this episode, we cover comprehensive strategies ranging from traditional avoidance techniques to cutting-edge treatments like omalizumab (Xolair) and Oral Immunotherapy (OIT).
While these treatments are promising, they are not cures. Dr. Gharfeh shares valuable insights on integrating these options into your allergy management plan. She also discusses how to determine whether Xolair or OIT might be the right choice for you or your child. Despite advancements, avoidance remains the cornerstone of food allergy management and must still be practiced even while undergoing treatment.
What We Cover in the Episode about Food Allergy Treatment OptionsEffective methods for food allergy avoidanceDeciphering packaged food labels and "may contain" statementsUnderstanding cross-contamination and cross-contactInsights into Xolair and its role in food allergy treatmentAn overview of Oral Immunotherapy (OIT)Guidance on choosing between Xolair and OITGUIDE: Food Allergen Alternative Names on Labels
Produced in partnership with The Allergy & Asthma Network.
Thanks to Genetech for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
- Visa fler
